文献速递头颈外科

商业保险人群中甲状腺切除术后低钙血症与镁紊乱的关联

Association of Hypocalcemia and Magnesium Disorders With Thyroidectomy in Commercially Insured Patients.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2020-01-01

镁紊乱与短期和长期低钙血症的关联最强,且低钙血症和镁紊乱均与1年医疗费用增加相关。

要点

  • 全甲状腺切除术后低钙血症常见但多在1年内缓解。
  • 镁紊乱与术后短期及长期低钙血症独立且强相关。
  • 女性、年轻、维生素D缺乏、颈部清扫及神经损伤增加低钙风险。

核心结论

  • 低钙血症在全甲状腺切除术后常见,但多数患者1年内缓解。
  • 镁紊乱与短期和长期低钙血症显著独立相关,并与更高医疗费用相关。

研究设计与样本

  • 回顾性横断面分析,使用MarketScan商业索赔与 encounter 数据库。

主要发现

  • 术后30天内低钙血症发生率为19.1%,1年时为4.4%。
  • 手术时镁紊乱发生率为2.1%。
  • 女性短期低钙血症OR为1.39(95%CI 1.29-1.50),长期OR为1.69(95%CI 1.52-1.89)。
  • 镁紊乱短期低钙血症OR为8.40(95%CI 7.21-9.79),长期OR为25.23(95%CI 19.80-32.17)。

临床怎么用

  • 全甲状腺切除术后应关注镁紊乱,可能作为降低低钙血症发生和费用的可干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hypocalcemia is a common complication of total thyroidectomy. OBJECTIVES: To identify factors associated with hypocalcemia after total thyroidectomy and to explore the association between hypocalcemia, magnesium disorders, and costs of care. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cross-sectional analysis was performed using data from the MarketScan Commercial Claim and Encounters database on 126 766 commercially insured patients younger than 65 years undergoing total thyroidectomy between January 1, 2010, and December 31, 2012. Statistical analysis was performed from January 1, 2016, to May 30, 2019. MAIN OUTCOMES AND MEASURES: Short- and long-term hypocalcemia and the costs of care were examined using multivariable regression modeling. RESULTS: Among the 126 766 patients in the study (81.6% women; mean age, 46.5 years [range, 18-64 years]), postoperative hypocalcemia was present in 19.1% of patients in the initial 30-day postoperative period and in 4.4% of patients at 1 year. Magnesium disorders were present in 2.1% of patients at the time of surgery. Short- and long-term hypocalcemia were significantly more likely in women (short-term: odds ratio [OR], 1.39 [95% CI, 1.29-1.50]; long-term: OR, 1.69 [95% CI, 1.52-1.89]), those younger than 40 years (short-term: OR for ages 40-64 years, 0.83 [95% CI, 0.78-0.87]; long-term: OR for ages 40-64 years, 0.73 [95% CI, 0.67-0.79]), those with a diagnosis of thyroiditis (short-term: OR, 1.48 [95% CI, 1.16-1.89]; long-term: OR, 1.60 [95% CI, 1.13-2.26]) or cancer (short-term: OR, 1.32 [95% CI, 1.05-1.67]; long-term: OR, 1.17 [95% CI, 0.83-1.63]), vitamin D deficiency (short-term: OR, 1.96 [95% CI, 1.74-2.21]; long-term: OR, 3.72 [95% CI, 3.30-4.18]), concurrent lateral neck dissection (short-term: OR, 1.51 [95% CI, 1.37-1.66]; long-term: OR, 1.95 [95% CI, 1.69-2.26]), concurrent central neck dissection (short-term: OR, 1.15 [95% CI, 1.07-1.24]; long-term: OR, 1.25 [95% CI, 1.12-1.40]), intraoperative parathyroid (short-term: OR, 1.58 [95% CI, 1.46-1.71]; and long-term: OR, 2.05 [95% CI, 1.82-2.31]) or recurrent laryngeal nerve injury (short-term: OR, 1.49 [95% CI, 1.27-1.74]; long-term: OR, 2.04 [95% CI, 1.64-2.54]), and magnesium disorders (short-term: OR, 8.40 [95% CI, 7.21-9.79]; long-term: OR, 25.23 [95% CI, 19.80-32.17]). Compared with the initial postoperative period, the odds of hypocalcemia decreased by 90.0% (OR, 0.10 [95% CI, 0.09-0.11]) at 6 months and 93.0% (OR, 0.07 [95% CI, 0.06-0.08]) at 1 year. After controlling for all other variables, magnesium disorders were associated with the highest odds of short- and long-term postoperative hypocalcemia. Hypocalcemia ($3392) and magnesium disorders ($14 314) were associated with increased mean incremental 1-year costs of care. CONCLUSIONS AND RELEVANCE: Hypocalcemia is common after total thyroidectomy but resolves in most patients by 1 year. Magnesium disorders are significantly independently associated with short- and long-term hypocalcemia and are associated with greater costs of care. These data suggest a potentially modifiable target to reduce the incidence and cost of long-term hypocalcemia at patient and systemic levels.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Liu RH, Razavi CR, Chang HY, et al. Association of Hypocalcemia and Magnesium Disorders With Thyroidectomy in Commercially Insured Patients. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 31917427. doi:10.1001/jamaoto.2019.4193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。